Literature DB >> 9521338

Expression of Gq alpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction.

H Ju1, S Zhao, P S Tappia, V Panagia, I M Dixon.   

Abstract

BACKGROUND: Large transmural myocardial infarction (MI) leads to maladaptive cardiac remodeling and places patients at increased risk of congestive heart failure. Angiotensin II, endothelin, and alpha1-adrenergic receptor agonists are implicated in the development of cardiac hypertrophy, interstitial fibrosis, and heart failure after MI. Because these agonists are coupled to and activate Gq alpha protein in the heart, the aim of the present study was to investigate Gq alpha expression and function in cardiac remodeling and heart failure after MI. METHODS AND
RESULTS: MI was produced in rats by ligation of the left coronary artery, and Gq alpha protein concentration, localization, and mRNA abundance were noted in surviving left ventricle remote from the infarct and in border and scar tissues from 8-week post-MI hearts with moderate heart failure. Immunohistochemical staining localized elevated Gq alpha expression in the scar and border tissues. Western analysis confirmed significant upregulation of Gq alpha proteins in these regions versus controls. Furthermore, Northern analysis revealed that the ratios of Gq alpha/GAPDH mRNA abundance in both scar and viable tissues from experimental hearts were significantly increased versus controls. Increased expression of phospholipase C (PLC)-beta1 and PLC-beta3 proteins was apparent in the scar and viable tissues after MI versus controls and is associated with increased PLC-beta1 activity in experimental hearts. Furthermore, inositol 1,4,5-tris-phosphate is significantly increased in the border and scar tissues compared with control values.
CONCLUSIONS: Upregulation of the Gq alpha/PLC-beta pathway was observed in the viable, border, and scar tissues in post-MI hearts. Gq alpha and PLC-beta may play important roles in scar remodeling as well as cardiac hypertrophy and fibrosis of the surviving tissue in post-MI rat heart. It is suggested that the Gq alpha/PLC-beta pathway may provide a possible novel target for altering postinfarct remodeling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521338     DOI: 10.1161/01.cir.97.9.892

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Abnormalities in sarcolemmal phospholipase D and phospholipase C isoenzymes and in their interactions in post-infarcted failing hearts.

Authors:  V Panagia; P S Tappia; C Yu; N Takeda; N S Dhalla
Journal:  Lipids       Date:  1999       Impact factor: 1.880

2.  Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

Authors:  Alia Shatanawi; Maritza J Romero; Jennifer A Iddings; Surabhi Chandra; Nagavedi S Umapathy; Alexander D Verin; Ruth B Caldwell; R William Caldwell
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

3.  Modeling hypertrophic IP3 transients in the cardiac myocyte.

Authors:  Michael Cooling; Peter Hunter; Edmund J Crampin
Journal:  Biophys J       Date:  2007-08-10       Impact factor: 4.033

4.  Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor.

Authors:  S Sandmann; M Yu; T Unger
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

5.  Pertussis toxin up-regulates angiotensin type 1 receptors through Toll-like receptor 4-mediated Rac activation.

Authors:  Motohiro Nishida; Reiko Suda; Yuichi Nagamatsu; Shihori Tanabe; Naoya Onohara; Michio Nakaya; Yasunori Kanaho; Takahiro Shibata; Koji Uchida; Hideki Sumimoto; Yoji Sato; Hitoshi Kurose
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

6.  Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.

Authors:  H Yoshida; M Takahashi; K Tanonaka; T Maki; Y Nasa; S Takeo
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 7.  Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure.

Authors:  Navneet S Rehsia; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

Review 8.  Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure.

Authors:  Brent N Reed; Sarah E Street; Brian C Jensen
Journal:  Heart Fail Clin       Date:  2014-08-14       Impact factor: 3.179

9.  SAcubitril/valsartan versus ramipril in patients with ST-segment Elevation Myocardial Infarction and cardiogenic SHOCK (SAVE-SHOCK): a pilot randomized controlled trial.

Authors:  Ahmed Rezq; Marwan Saad; Mostafa El Nozahi
Journal:  Am J Cardiovasc Dis       Date:  2021-12-15

10.  An autoinhibitory helix in the C-terminal region of phospholipase C-β mediates Gαq activation.

Authors:  Angeline M Lyon; Valerie M Tesmer; Vishan D Dhamsania; David M Thal; Joanne Gutierrez; Shoaib Chowdhury; Krishna C Suddala; John K Northup; John J G Tesmer
Journal:  Nat Struct Mol Biol       Date:  2011-08-07       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.